NO20053715D0 - 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk - Google Patents
10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykkInfo
- Publication number
- NO20053715D0 NO20053715D0 NO20053715A NO20053715A NO20053715D0 NO 20053715 D0 NO20053715 D0 NO 20053715D0 NO 20053715 A NO20053715 A NO 20053715A NO 20053715 A NO20053715 A NO 20053715A NO 20053715 D0 NO20053715 D0 NO 20053715D0
- Authority
- NO
- Norway
- Prior art keywords
- dialkylprostanoic
- agents
- acid derivatives
- intraocular pressure
- lowering intraocular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/365,369 US6875787B2 (en) | 2003-02-11 | 2003-02-11 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| US10/772,720 US20040235958A1 (en) | 2003-02-11 | 2004-02-04 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| PCT/US2004/003433 WO2004071428A2 (en) | 2003-02-11 | 2004-02-06 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20053715D0 true NO20053715D0 (no) | 2005-08-01 |
| NO20053715L NO20053715L (no) | 2005-10-27 |
| NO334659B1 NO334659B1 (no) | 2014-05-12 |
Family
ID=32871611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053715A NO334659B1 (no) | 2003-02-11 | 2005-08-01 | 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1608309B1 (no) |
| JP (1) | JP5319065B2 (no) |
| KR (1) | KR101077461B1 (no) |
| AU (1) | AU2004211936B2 (no) |
| BR (1) | BRPI0407400A (no) |
| CA (1) | CA2515631C (no) |
| MX (1) | MXPA05008431A (no) |
| NO (1) | NO334659B1 (no) |
| NZ (1) | NZ541352A (no) |
| PL (1) | PL209130B1 (no) |
| RU (1) | RU2336081C2 (no) |
| WO (1) | WO2004071428A2 (no) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| JP2008518013A (ja) * | 2004-10-26 | 2008-05-29 | アラーガン、インコーポレイテッド | プロスタグランジンep4アゴニストによる処置方法およびデリバリー方法 |
| AU2012200514B2 (en) * | 2005-03-17 | 2014-03-06 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| CN105566192B (zh) * | 2006-10-02 | 2019-01-22 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药 |
| JP5378219B2 (ja) * | 2006-10-02 | 2013-12-25 | テックフィールズ バイオケム カンパニー リミテッド | 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ |
| US8455547B2 (en) * | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| US7732443B2 (en) * | 2008-03-18 | 2010-06-08 | Yariv Donde | Therapeutic substituted cyclopentanes |
| JP2011519939A (ja) * | 2008-05-09 | 2011-07-14 | アラーガン インコーポレイテッド | 治療用化合物 |
| EP2488168A1 (en) | 2009-10-14 | 2012-08-22 | Gemmus Pharma Inc. | Combination therapy treatment for viral infections |
| RU2013108394A (ru) * | 2010-07-30 | 2014-09-10 | Аллерган, Инк. | Соединения и способы восстановления кожи |
| WO2012024376A1 (en) * | 2010-08-17 | 2012-02-23 | Allergan, Inc. | Ep2 or ep4 agonists for treating corneal haze |
| AU2014305843B2 (en) | 2013-08-09 | 2019-08-29 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4117014A (en) | 1976-01-09 | 1978-09-26 | Abbott Laboratories | Prostaglandin derivatives |
| JPS59101458A (ja) * | 1982-12-01 | 1984-06-12 | Nippon Iyakuhin Kogyo Kk | 新規なチアプロスタグランジン誘導体及びその製法 |
| JPS632972A (ja) * | 1986-06-20 | 1988-01-07 | Nippon Iyakuhin Kogyo Kk | 新規プロスタグランジンe↓1誘導体及びその製法 |
| US4994274A (en) * | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
| US5034413A (en) * | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
| JP4520738B2 (ja) * | 2001-06-14 | 2010-08-11 | アラーガン インコーポレイテッド | 眼圧降下剤としての3、7、または3および7チアまたはオキサプロスタン酸誘導体 |
-
2004
- 2004-02-06 AU AU2004211936A patent/AU2004211936B2/en not_active Ceased
- 2004-02-06 JP JP2006503371A patent/JP5319065B2/ja not_active Expired - Lifetime
- 2004-02-06 NZ NZ541352A patent/NZ541352A/en not_active IP Right Cessation
- 2004-02-06 BR BRPI0407400-9A patent/BRPI0407400A/pt not_active Application Discontinuation
- 2004-02-06 CA CA2515631A patent/CA2515631C/en not_active Expired - Fee Related
- 2004-02-06 RU RU2005129072/04A patent/RU2336081C2/ru active
- 2004-02-06 PL PL378421A patent/PL209130B1/pl unknown
- 2004-02-06 KR KR1020057014697A patent/KR101077461B1/ko not_active Expired - Fee Related
- 2004-02-06 EP EP04709028A patent/EP1608309B1/en not_active Expired - Lifetime
- 2004-02-06 MX MXPA05008431A patent/MXPA05008431A/es active IP Right Grant
- 2004-02-06 WO PCT/US2004/003433 patent/WO2004071428A2/en not_active Ceased
-
2005
- 2005-08-01 NO NO20053715A patent/NO334659B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1608309B1 (en) | 2012-07-11 |
| RU2336081C2 (ru) | 2008-10-20 |
| MXPA05008431A (es) | 2005-10-19 |
| KR101077461B1 (ko) | 2011-10-26 |
| EP1608309A2 (en) | 2005-12-28 |
| JP2006517587A (ja) | 2006-07-27 |
| RU2005129072A (ru) | 2006-02-27 |
| WO2004071428A3 (en) | 2005-11-10 |
| AU2004211936A1 (en) | 2004-08-26 |
| AU2004211936B2 (en) | 2008-09-11 |
| JP5319065B2 (ja) | 2013-10-16 |
| NO334659B1 (no) | 2014-05-12 |
| CA2515631C (en) | 2013-08-20 |
| WO2004071428A2 (en) | 2004-08-26 |
| PL209130B1 (pl) | 2011-07-29 |
| CA2515631A1 (en) | 2004-08-26 |
| BRPI0407400A (pt) | 2006-02-21 |
| NZ541352A (en) | 2007-12-21 |
| NO20053715L (no) | 2005-10-27 |
| KR20050101202A (ko) | 2005-10-20 |
| PL378421A1 (pl) | 2006-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2263674T3 (da) | 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk | |
| NO20041567L (no) | 1,8-nafthyridinderivater som antidiabetiske midler | |
| DK1638928T3 (da) | N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider | |
| NO20052993D0 (no) | 4,5-diaryltiazolderivater som CB-1 ligander. | |
| DE60314124D1 (de) | 2-(2,6-dichlorphenyl)-diarylimidazole | |
| DK1592457T3 (da) | Folat-vinblastin-konjugat som lægemiddel | |
| DK1414803T3 (da) | Pyrazolylcarboxanilider som fungicider | |
| DK1317431T3 (da) | Polyarylcarboxamider, der er anvendelige som lipidsænkende midler | |
| IS8509A (is) | Ný 2-heteróarýl-setin bensímídasól afleiða | |
| MX268884B (es) | Derivados de merocianina para uso cosmetico. | |
| DK1585749T3 (da) | Diazepinoindol-derivater som kinaseinhibitorer | |
| NO20050426L (no) | Arylkarbonylderivater som terapeutiske midler | |
| NO20043022L (no) | 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister | |
| WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
| DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
| NO20052884D0 (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
| NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
| IL181766A0 (en) | A process for the preparation of [1,4,5]-oxadiazepine derivatives | |
| AU2003250475A8 (en) | 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors | |
| NO20043794L (no) | Benzensulfonamidderivater som antipsykotiske midler | |
| DK1575948T3 (da) | Pyridodiaziner som plantefungicider | |
| NO20053099D0 (no) | Fremgangsmate for a fremstille optisk rene aktive forbindelser. | |
| NO20053715D0 (no) | 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk | |
| DK1556377T3 (da) | Cyclopropylthienylcarboxamider som fungicider | |
| NO20044092L (no) | Oftalmisk sammensetning som innbefatter ascomycin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |